These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23871822)

  • 1. Concomitant administration of GonaCon™ and rabies vaccine in female dogs (Canis familiaris) in Mexico.
    Vargas-Pino F; Gutiérrez-Cedillo V; Canales-Vargas EJ; Gress-Ortega LR; Miller LA; Rupprecht CE; Bender SC; García-Reyna P; Ocampo-López J; Slate D
    Vaccine; 2013 Sep; 31(40):4442-7. PubMed ID: 23871822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of GonaCon™ vaccine on black-tailed prairie dogs: immune response and health effects.
    Yoder CA; Miller LA
    Vaccine; 2010 Dec; 29(2):233-9. PubMed ID: 21055491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No adverse effects of simultaneous vaccination with the immunocontraceptive GonaCon and a commercial rabies vaccine on rabies virus neutralizing antibody production in dogs.
    Bender SC; Bergman DL; Wenning KM; Miller LA; Slate D; Jackson FR; Rupprecht CE
    Vaccine; 2009 Nov; 27(51):7210-3. PubMed ID: 19925955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
    Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH
    Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabies control in Mexico.
    Lucas CH; Pino FV; Baer G; Morales PK; Cedillo VG; Blanco MA; Avila MH
    Dev Biol (Basel); 2008; 131():167-75. PubMed ID: 18634477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies.
    Zhang S; Liu Y; Fooks AR; Zhang F; Hu R
    Vaccine; 2008 Jan; 26(3):345-50. PubMed ID: 18083277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of combined vaccines for rabies and immunocontraception.
    Wu X; Franka R; Svoboda P; Pohl J; Rupprecht CE
    Vaccine; 2009 Nov; 27(51):7202-9. PubMed ID: 19925954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New steps in the control of canine rabies in India.
    Pradhan HK; Gurbuxani JP; Cliquet F; Pattnaik B; Patil SS; Regnault A; Begouen H; Guiot AL; Sood R; Mahl P; Singh R; Picard E; Aubert MF; Barrat J; Meslin FX
    Dev Biol (Basel); 2008; 131():157-66. PubMed ID: 18634476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody response to an anti-rabies vaccine in a dog population under field conditions in Bolivia.
    Suzuki K; González ET; Ascarrunz G; Loza A; Pérez M; Ruiz G; Rojas L; Mancilla K; Pereira JA; Guzman JA; Pecoraro MR
    Zoonoses Public Health; 2008 Oct; 55(8-10):414-20. PubMed ID: 18399941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine.
    Deshpande AK; Londhe VA; Akarte S; Briggs D
    J Assoc Physicians India; 2003 Jul; 51():655-8. PubMed ID: 14621031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermotolerance of an inactivated rabies vaccine for dogs.
    Lankester FJ; Wouters PAWM; Czupryna A; Palmer GH; Mzimbiri I; Cleaveland S; Francis MJ; Sutton DJ; Sonnemans DGP
    Vaccine; 2016 Nov; 34(46):5504-5511. PubMed ID: 27729174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies virus.
    Lodmell DL; Ewalt LC; Parnell MJ; Rupprecht CE; Hanlon CA
    Vaccine; 2006 Jan; 24(4):412-6. PubMed ID: 16153757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and bait acceptance of vaccinia vectored rabies glycoprotein vaccine in captive foxes (Vulpes vulpes), raccoon dogs (Nyctereutes procyonoides) and dogs (Canis familiaris).
    Cliquet F; Barrat J; Guiot AL; Caël N; Boutrand S; Maki J; Schumacher CL
    Vaccine; 2008 Aug; 26(36):4627-38. PubMed ID: 18620017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral vaccination of dogs with recombinant rabies virus vaccines.
    Rupprecht CE; Hanlon CA; Blanton J; Manangan J; Morrill P; Murphy S; Niezgoda M; Orciari LA; Schumacher CL; Dietzschold B
    Virus Res; 2005 Jul; 111(1):101-5. PubMed ID: 15896409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and efficacy of an in-house developed cell-culture derived veterinarian rabies vaccine.
    Kallel H; Diouani MF; Loukil H; Trabelsi K; Snoussi MA; Majoul S; Rourou S; Dellagi K
    Vaccine; 2006 May; 24(22):4856-62. PubMed ID: 16600442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field trials of a very potent rabies DNA vaccine which induced long lasting virus neutralizing antibodies and protection in dogs in experimental conditions.
    Bahloul C; Taieb D; Diouani MF; Ahmed SB; Chtourou Y; B'chir BI; Kharmachi H; Dellagi K
    Vaccine; 2006 Feb; 24(8):1063-72. PubMed ID: 16213633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.
    Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T
    Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab).
    Ashwathnarayana DH; Madhusudana SN; Sampath G; Sathpathy DM; Mankeshwar R; Ravish HH; Ullas PT; Behra TR; Sudarshan MK; Gangaboraiah ; Shamanna M
    Vaccine; 2009 Dec; 28(1):148-51. PubMed ID: 19818720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of a reduced-dose whole killed rabies vaccine is significantly enhanced by ISCOMATRIX™ adjuvant, Merck amorphous aluminum hydroxylphosphate sulfate (MAA) or a synthetic TLR9 agonist in rhesus macaques.
    DiStefano D; Antonello JM; Bett AJ; Medi MB; Casimiro DR; ter Meulen J
    Vaccine; 2013 Oct; 31(42):4888-93. PubMed ID: 23941913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.